ALVARIUM TIEDEMANN ($ALTI) is expected to release its quarterly earnings data on Thursday, March 13th after market close, per Finnhub. Analysts are expecting revenue of $76,092,000 and earnings of $0.02 per share.
You can see Quiver Quantitative's $ALTI stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ALVARIUM TIEDEMANN Insider Trading Activity
ALVARIUM TIEDEMANN insiders have traded $ALTI stock on the open market 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ALTI stock by insiders over the last 6 months:
- SPIROS MALIAGROS (Pres., Strategic Alternatives) has made 0 purchases and 5 sales selling 19,686 shares for an estimated $82,160.
- HOLDINGS ILWADDI purchased 5,854 shares for an estimated $22,654
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ALVARIUM TIEDEMANN Hedge Fund Activity
We have seen 32 institutional investors add shares of ALVARIUM TIEDEMANN stock to their portfolio, and 21 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BOKF, NA added 595,894 shares (+inf%) to their portfolio in Q4 2024, for an estimated $2,627,892
- UBS GROUP AG added 408,705 shares (+2539.6%) to their portfolio in Q4 2024, for an estimated $1,802,389
- STATE STREET CORP added 133,719 shares (+24.8%) to their portfolio in Q4 2024, for an estimated $589,700
- NEWEDGE WEALTH, LLC added 113,700 shares (+inf%) to their portfolio in Q4 2024, for an estimated $501,417
- BLACKROCK, INC. added 107,410 shares (+4.2%) to their portfolio in Q4 2024, for an estimated $473,678
- EXODUSPOINT CAPITAL MANAGEMENT, LP removed 74,472 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $328,421
- JPMORGAN CHASE & CO added 53,847 shares (+198.8%) to their portfolio in Q4 2024, for an estimated $237,465
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
